Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy-A Meta-Analysis.
Rao KN, Pai PS, Dange P, Kowalski LP, Strojan P, Mäkitie AA, Guntinas-Lichius O, Robbins KT, Rodrigo JP, Eisbruch A, Takes RP, de Bree R, Coca-Pelaz A, Piazza C, Chiesa-Estomba C, López F, Saba NF, Rinaldo A, Ferlito A. Rao KN, et al. Among authors: pai ps. Biomedicines. 2023 Jul 28;11(8):2128. doi: 10.3390/biomedicines11082128. Biomedicines. 2023. PMID: 37626625 Free PMC article. Review.
Real world data on long term outcome of neoadjuvant chemotherapy in locally advanced esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation - Results from a single centre study.
Saha S, Patil VM, Noronha V, Menon N, Kumar Singh A, Patlekar G, Yadav N, Pai PS, Chaukar DA, Chaturvedi P, Ghosh Laskar S, Prabhash K. Saha S, et al. Among authors: pai ps. Oral Oncol. 2023 Sep;144:106486. doi: 10.1016/j.oraloncology.2023.106486. Epub 2023 Jul 4. Oral Oncol. 2023. PMID: 37413771
Neoadjuvant chemotherapy in a rare type of very locally advanced sinonasal carcinomas - long-term results from a tertiary care centre.
Saha S, Patil VM, Noronha V, Menon N, Singh AK, Suman M, Agrawal A, Khaddar S, Chakraborty S, Pai PS, Chaukar DA, Chaturvedi P, Laskar SG, Prabhash K. Saha S, et al. Among authors: pai ps. Ecancermedicalscience. 2023 May 11;17:1549. doi: 10.3332/ecancer.2023.1549. eCollection 2023. Ecancermedicalscience. 2023. PMID: 37377683 Free PMC article.
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.
Patil VM, Noronha V, Menon N, Singh A, Ghosh-Laskar S, Budrukkar A, Bhattacharjee A, Swain M, Mathrudev V, Nawale K, Balaji A, Peelay Z, Alone M, Pathak S, Mahajan A, Kumar S, Purandare N, Agarwal A, Puranik A, Pendse S, Reddy Yallala M, Sahu H, Kapu V, Dey S, Choudhary J, Krishna MR, Shetty A, Karuvandan N, Ravind R, Rai R, Jobanputra K, Chaturvedi P, Pai PS, Chaukar D, Nair S, Thiagarajan S, Prabhash K. Patil VM, et al. Among authors: pai ps. J Clin Oncol. 2023 May 1;41(13):2350-2361. doi: 10.1200/JCO.22.00980. Epub 2023 Jan 27. J Clin Oncol. 2023. PMID: 36706347 Clinical Trial.
Anaplastic Cancer: Our Experience.
Kanteti APK, Ghose J, Patil VM, Tamhankar AS, Abraham G, Noronha V, Laskar SG, Menon NS, Pai PS, Prabhash K. Kanteti APK, et al. Among authors: pai ps. Indian J Surg Oncol. 2022 Dec;13(4):789-796. doi: 10.1007/s13193-022-01576-w. Epub 2022 Jul 6. Indian J Surg Oncol. 2022. PMID: 36687234 Free PMC article.
91 results